The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer
This clinical study shows the prognosis value of a new threshold of CTC number and meanwhile the guidance value of cHER2 status in anti-HER2 therapy.
Authors
- Si‐Mei Shi (ORCID: https://orcid.org/0000-0003-4634-0345)
- Chao Han (ORCID: https://orcid.org/0000-0003-1828-2854)
- Ruoxi Hong (ORCID: https://orcid.org/0000-0002-2919-1467)
- Mei Li (ORCID: https://orcid.org/0000-0002-7887-5048)
- Shusen Wang (ORCID: https://orcid.org/0000-0003-0139-5780)
- Liye Wang
- Yong Chen (ORCID: https://orcid.org/0000-0002-2903-8753)
- Feng Ye
Institutions
- Centre National de la Recherche Scientifique (FR)
- Sun Yat-sen University (CN)
- Université Paris Sciences et Lettres (FR)
- École Normale Supérieure - PSL (FR)
- Sorbonne Université (FR)
- Beijing VDJBio (China) (CN)
- Sun Yat-sen University Cancer Center (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1186/s12885-024-12818-1
- Citations
- 8
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 2.26
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province